Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Two new compounds were found to effectively reduce hair growth in mice.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Acitretin effectively treats severe hypertrophic lichen planus.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

PP405 may help hair growth by activating hair follicle stem cells.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.